For example, ghrelin, an orexigenic (appetite stimulant) gut hormone, post-meal plasma levels remain high in PWS patients compared to healthy lean control and non-PWS patients suffering from obesity, specifically prior to obesity onset, leading to a delayed satiety sensation and an uncontrolled drive to eat [226,227,228]. This evidence concerns the gene GHRL and obesity disorder.